SporeGen and Destiny advance research collaboration
Duo have partnered on developing a biotherapeutic therapy for flu and COVID-19
Read More
Tag: SporeGen
Destiny, SporeGen collaborate on COVID-19 prevention spray
Development of SPOR-COV is supported by a grant from Innovate UK
Read More
- King’s Doctoral Training Centre to investigate MS symptom management
- Agenda announced for FlyPharma Vienna 2024
- Therapy reprogrammes immune cells to shrink prostate and bladder cancers
- Researchers combine herpes virus with cancer vaccine to treat brain cancer in children
- UK MRC and AstraZeneca partner for translational clinical research
